S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
S&P 500   4,976.10 (-0.70%)
DOW   37,897.35 (+0.32%)
QQQ   415.59 (-1.85%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
Free Trial
CNSX:BUX

Biomark Diagnostics (BUX) Stock Price, News & Analysis

→ The #1 Crypto for 2024 (From InvestorPlace) (Ad)
Free BUX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
11,500 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
BUX stock logo

About Biomark Diagnostics Stock (CNSX:BUX)

BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.

BUX Stock News Headlines

April 18, 2024 | finance.yahoo.com
BioMark Announces Warrant Extension and Granting of Options
April 9, 2024 | finance.yahoo.com
BioMark to Advance Development of Cancer Treatment for Glioblastoma
April 19, 2024 | Banyan Hill Publishing (Ad)
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
February 28, 2024 | finance.yahoo.com
BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities
February 26, 2024 | finance.yahoo.com
Theresa Peterson Joins Biomark's Advisory Team
February 20, 2024 | fortune.com
Quest Diagnostics
December 29, 2023 | finanznachrichten.de
BioMark Diagnostics, Inc.: BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
December 29, 2023 | finance.yahoo.com
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
April 19, 2024 | Banyan Hill Publishing (Ad)
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
December 4, 2023 | markets.businessinsider.com
BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay
November 28, 2023 | finanznachrichten.de
BioMark Diagnostics, Inc.: BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term
November 14, 2023 | finance.yahoo.com
BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives
October 24, 2023 | finance.yahoo.com
BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium
August 30, 2023 | finance.yahoo.com
BioMark Appoints Kevin J. Cosgriff to Its Strategic Advisory Team
August 8, 2023 | finance.yahoo.com
Japan Patent Office (JPO) Issued BioMark Patent with Claims Covering Its Lung Cancer Urine Based Liquid Biopsy Assay
July 25, 2023 | finanznachrichten.de
BioMark Diagnostics, Inc.: BioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Update
July 25, 2023 | finance.yahoo.com
BioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Update
July 17, 2023 | mirror.co.uk
Gary Lineker and ex-stepdaughter Ella Bux put on a smiley display at Wimbledon
June 5, 2023 | finance.yahoo.com
BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meeting
May 31, 2023 | finance.yahoo.com
BioMark Announces the U.S. Patent and Trademark Office Granted Patent with Claims Covering Its Lung Cancer Liquid Biopsy Assay
May 5, 2023 | marketwatch.com
Liver Cancer Diagnostic Tests Market to Witness Huge Growth with Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SAS
May 3, 2023 | markets.businessinsider.com
BioMark Latest Results Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023
April 10, 2023 | msn.com
Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay
March 16, 2023 | finanznachrichten.de
BioMark Diagnostics, Inc.: BioMark Presents Novel Liquid Biopsy Data in Pulmonary Neuroendocrine Tumors
March 16, 2023 | finance.yahoo.com
BioMark Presents Novel Liquid Biopsy Data in Pulmonary Neuroendocrine Tumors
March 1, 2023 | finanznachrichten.de
BioMark Diagnostics, Inc.: BioMark Provides Third Quarter Operational Update and 2023 Outlook
March 1, 2023 | finance.yahoo.com
BioMark Provides Third Quarter Operational Update and 2023 Outlook
See More Headlines
Receive BUX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomark Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CNSX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
CNSX:BUX
CUSIP
N/A
CIK
N/A
Web
www.biomarkdiagnostics.com
Phone
604-370-0779
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover
The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

BUX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Biomark Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biomark Diagnostics investors own include Stantec (STN) and IQE (IQE).

How do I buy shares of Biomark Diagnostics?

Shares of BUX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:BUX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends